Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Linperlisib Tablets

Approval Number

国药准字H20220030

Company上海璎黎药业有限公司

Registration Date

November 8, 2022

Drug Information

Generic Name

林普利塞片

Trade Name

因他瑞

Dosage Form

片剂

Strength

20mg

Drug Type

化学药品

Registration Date

November 8, 2022

Company Information

Applicant Company

Company Name上海璎黎药业有限公司

Company Address

上海市浦东新区秀浦路2555号8幢2层

Manufacturing Company

Company Name江苏宣泰药业有限公司

Company Address

南通市海门区滨江街道珠海路163号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

林普利塞片 - NMPA 批准文号 | MedPath